Skip to main content
SpringerLink
Log in

Erfolgreiche First-Line-Chemotherapie bei metastasiertem Brustkrebs fortsetzen?

  • Literatur kompakt
  • Published:
gynäkologie + geburtshilfe Aims and scope

Eine Chemotherapie wird bei metastasiertem Brustkrebs vor allem für spezielle Subgruppen empfohlen, z. B. bei Patientinnen mit Hormonrezeptor-negativen Tumoren. Die optimale Dauer der First-Line-Chemotherapie ist jedoch strittig.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Park HY et al. Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02. J Clin Oncol. 2013;31(14):1732–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Brigitte Schalhorn &  Marina Wirtz

Authors
  1. Brigitte Schalhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina Wirtz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schalhorn, B., Wirtz, M. Erfolgreiche First-Line-Chemotherapie bei metastasiertem Brustkrebs fortsetzen?. gynäkologie + geburtshilfe 18, 14 (2013). https://doi.org/10.1007/s15013-013-0302-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15013-013-0302-y

Search

Navigation